Micro Bio Processor Development Kit for Wireless Neural Implants.

Micro Bio Processor version 1.5 (MBPv15) Development Kit is specially engineered to support various function-alities of implantable devices such as bio-signal sensing, neural stimulation, and dual-band wireless connectivity & charging. It provides a convenient way to evaluate the MBPv15 chip solution as a system component by a modular design of hardware and software. As a result, MBPv15 chip solution enables to develop wireless neural implants in a mm-scale form factor with ultra-low power consumption by achieving 1.6 mW for neural spike detection and 9.8 mW for neural stimulation, respectively.

Long-Term Non Anesthetic Preclinical Study Available Extra-Cranial Brain Activator (ECBA) System for the Future Minimally Invasive Human Neuro Modulation.

In recent years, electroceuticals have been spotlighted as an emerging treatment for various severe chronic brain diseases, owing to their intrinsic advantage of electrical interaction with the brain, which is the most electrically active organ. However, the majority of research has verified only the short-term efficacy through acute studies in laboratory tests owing to the lack of a reliable miniaturized platform for long-term animal studies. The construction of a sufficient integrated system for such a platform is extremely difficult because it requires multi-disciplinary work using state-of-the-art technologies in a wide range of fields. In this study, we propose a complete system of an implantable platform for long-term preclinical brain studies. Our proposed system, the extra-cranial brain activator (ECBA), consists of a titanium-packaged implantable module and a helmet-type base station that powers the module wirelessly. The ECBA can also be controlled by a remote handheld device. Using the ECBA, we performed a long-term non-anesthetic study with multiple canine subjects, and the resulting PET-CT scans demonstrated remarkable enhancement in brain activity relating to memory and sensory skills. Furthermore, the histological analysis and high-temperature aging test confirmed the reliability of the system for up to 31 months. Hence, the proposed ECBA system is expected to lead a new paradigm of human neuromodulation studies in the near future.